nodes	percent_of_prediction	percent_of_DWPC	metapath
Tapentadol—Urinary hesitation—Lamivudine—hepatitis B	0.0277	0.0322	CcSEcCtD
Tapentadol—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.0153	0.0178	CcSEcCtD
Tapentadol—Upper respiratory tract infection—Entecavir—hepatitis B	0.0143	0.0167	CcSEcCtD
Tapentadol—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.0136	0.0158	CcSEcCtD
Tapentadol—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.0132	0.0153	CcSEcCtD
Tapentadol—Nasopharyngitis—Telbivudine—hepatitis B	0.0131	0.0152	CcSEcCtD
Tapentadol—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.0129	0.015	CcSEcCtD
Tapentadol—Drug interaction—Lamivudine—hepatitis B	0.0122	0.0143	CcSEcCtD
Tapentadol—Abdominal discomfort—Telbivudine—hepatitis B	0.0121	0.0141	CcSEcCtD
Tapentadol—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.0119	0.0138	CcSEcCtD
Tapentadol—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.0118	0.0138	CcSEcCtD
Tapentadol—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.0118	0.0137	CcSEcCtD
Tapentadol—Upper respiratory tract infection—Telbivudine—hepatitis B	0.0117	0.0137	CcSEcCtD
Tapentadol—Immune system disorder—Entecavir—hepatitis B	0.0111	0.013	CcSEcCtD
Tapentadol—Mental disorder—Entecavir—hepatitis B	0.0108	0.0126	CcSEcCtD
Tapentadol—Malnutrition—Entecavir—hepatitis B	0.0107	0.0125	CcSEcCtD
Tapentadol—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.0105	0.0122	CcSEcCtD
Tapentadol—Hypoaesthesia—Telbivudine—hepatitis B	0.0101	0.0117	CcSEcCtD
Tapentadol—Connective tissue disorder—Telbivudine—hepatitis B	0.00994	0.0116	CcSEcCtD
Tapentadol—Cough—Adefovir Dipivoxil—hepatitis B	0.00913	0.0106	CcSEcCtD
Tapentadol—Mediastinal disorder—Telbivudine—hepatitis B	0.00912	0.0106	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00906	0.0106	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00884	0.0103	CcSEcCtD
Tapentadol—Malnutrition—Telbivudine—hepatitis B	0.00881	0.0103	CcSEcCtD
Tapentadol—Anaphylactic shock—Entecavir—hepatitis B	0.00875	0.0102	CcSEcCtD
Tapentadol—Infection—Entecavir—hepatitis B	0.00869	0.0101	CcSEcCtD
Tapentadol—Nervous system disorder—Entecavir—hepatitis B	0.00858	0.00999	CcSEcCtD
Tapentadol—Skin disorder—Entecavir—hepatitis B	0.0085	0.0099	CcSEcCtD
Tapentadol—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00837	0.00975	CcSEcCtD
Tapentadol—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00829	0.00966	CcSEcCtD
Tapentadol—Insomnia—Entecavir—hepatitis B	0.00791	0.00922	CcSEcCtD
Tapentadol—Somnolence—Entecavir—hepatitis B	0.00778	0.00906	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00778	0.00906	CcSEcCtD
Tapentadol—Dyspepsia—Entecavir—hepatitis B	0.0077	0.00897	CcSEcCtD
Tapentadol—Cough—Telbivudine—hepatitis B	0.00768	0.00895	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Entecavir—hepatitis B	0.00755	0.0088	CcSEcCtD
Tapentadol—Fatigue—Entecavir—hepatitis B	0.00754	0.00879	CcSEcCtD
Tapentadol—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00751	0.00875	CcSEcCtD
Tapentadol—Arthralgia—Telbivudine—hepatitis B	0.0075	0.00873	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00745	0.00867	CcSEcCtD
Tapentadol—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.00742	0.00864	CcSEcCtD
Tapentadol—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00742	0.00864	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00737	0.00858	CcSEcCtD
Tapentadol—Nasopharyngitis—Lamivudine—hepatitis B	0.00737	0.00858	CcSEcCtD
Tapentadol—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.00727	0.00847	CcSEcCtD
Tapentadol—Nervous system disorder—Telbivudine—hepatitis B	0.00705	0.00821	CcSEcCtD
Tapentadol—Skin disorder—Telbivudine—hepatitis B	0.00698	0.00813	CcSEcCtD
Tapentadol—Abdominal discomfort—Lamivudine—hepatitis B	0.00683	0.00795	CcSEcCtD
Tapentadol—Pollakiuria—Lamivudine—hepatitis B	0.00658	0.00766	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00655	0.00763	CcSEcCtD
Tapentadol—Insomnia—Telbivudine—hepatitis B	0.0065	0.00757	CcSEcCtD
Tapentadol—Paraesthesia—Telbivudine—hepatitis B	0.00645	0.00752	CcSEcCtD
Tapentadol—Depression—Lamivudine—hepatitis B	0.00633	0.00738	CcSEcCtD
Tapentadol—Dyspepsia—Telbivudine—hepatitis B	0.00633	0.00737	CcSEcCtD
Tapentadol—Asthenia—Entecavir—hepatitis B	0.00628	0.00731	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Telbivudine—hepatitis B	0.0062	0.00723	CcSEcCtD
Tapentadol—Fatigue—Telbivudine—hepatitis B	0.0062	0.00722	CcSEcCtD
Tapentadol—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00612	0.00713	CcSEcCtD
Tapentadol—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00604	0.00703	CcSEcCtD
Tapentadol—Diarrhoea—Entecavir—hepatitis B	0.00599	0.00697	CcSEcCtD
Tapentadol—Feeling abnormal—Telbivudine—hepatitis B	0.00592	0.0069	CcSEcCtD
Tapentadol—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00584	0.0068	CcSEcCtD
Tapentadol—Dizziness—Entecavir—hepatitis B	0.00579	0.00674	CcSEcCtD
Tapentadol—Hypoaesthesia—Lamivudine—hepatitis B	0.00567	0.00661	CcSEcCtD
Tapentadol—Connective tissue disorder—Lamivudine—hepatitis B	0.0056	0.00653	CcSEcCtD
Tapentadol—Vomiting—Entecavir—hepatitis B	0.00556	0.00648	CcSEcCtD
Tapentadol—Rash—Entecavir—hepatitis B	0.00552	0.00643	CcSEcCtD
Tapentadol—Dermatitis—Entecavir—hepatitis B	0.00551	0.00642	CcSEcCtD
Tapentadol—Headache—Entecavir—hepatitis B	0.00548	0.00638	CcSEcCtD
Tapentadol—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00543	0.00632	CcSEcCtD
Tapentadol—Rash—Adefovir Dipivoxil—hepatitis B	0.00538	0.00627	CcSEcCtD
Tapentadol—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00538	0.00626	CcSEcCtD
Tapentadol—Headache—Adefovir Dipivoxil—hepatitis B	0.00535	0.00623	CcSEcCtD
Tapentadol—Nausea—Entecavir—hepatitis B	0.0052	0.00605	CcSEcCtD
Tapentadol—Asthenia—Telbivudine—hepatitis B	0.00516	0.00601	CcSEcCtD
Tapentadol—Immune system disorder—Lamivudine—hepatitis B	0.00515	0.006	CcSEcCtD
Tapentadol—Mediastinal disorder—Lamivudine—hepatitis B	0.00514	0.00599	CcSEcCtD
Tapentadol—Chills—Lamivudine—hepatitis B	0.00512	0.00596	CcSEcCtD
Tapentadol—Pruritus—Telbivudine—hepatitis B	0.00508	0.00592	CcSEcCtD
Tapentadol—Nausea—Adefovir Dipivoxil—hepatitis B	0.00507	0.00591	CcSEcCtD
Tapentadol—Malnutrition—Lamivudine—hepatitis B	0.00496	0.00578	CcSEcCtD
Tapentadol—Diarrhoea—Telbivudine—hepatitis B	0.00492	0.00573	CcSEcCtD
Tapentadol—Tension—Lamivudine—hepatitis B	0.00487	0.00567	CcSEcCtD
Tapentadol—Nervousness—Lamivudine—hepatitis B	0.00482	0.00561	CcSEcCtD
Tapentadol—Dizziness—Telbivudine—hepatitis B	0.00475	0.00554	CcSEcCtD
Tapentadol—Tremor—Lamivudine—hepatitis B	0.00465	0.00542	CcSEcCtD
Tapentadol—Vomiting—Telbivudine—hepatitis B	0.00457	0.00532	CcSEcCtD
Tapentadol—Angioedema—Lamivudine—hepatitis B	0.00453	0.00528	CcSEcCtD
Tapentadol—Rash—Telbivudine—hepatitis B	0.00453	0.00528	CcSEcCtD
Tapentadol—Dermatitis—Telbivudine—hepatitis B	0.00453	0.00527	CcSEcCtD
Tapentadol—Headache—Telbivudine—hepatitis B	0.0045	0.00524	CcSEcCtD
Tapentadol—Vertigo—Lamivudine—hepatitis B	0.00446	0.00519	CcSEcCtD
Tapentadol—Syncope—Lamivudine—hepatitis B	0.00445	0.00518	CcSEcCtD
Tapentadol—Loss of consciousness—Lamivudine—hepatitis B	0.00436	0.00508	CcSEcCtD
Tapentadol—Cough—Lamivudine—hepatitis B	0.00433	0.00504	CcSEcCtD
Tapentadol—Convulsion—Lamivudine—hepatitis B	0.0043	0.00501	CcSEcCtD
Tapentadol—Nausea—Telbivudine—hepatitis B	0.00427	0.00497	CcSEcCtD
Tapentadol—Arthralgia—Lamivudine—hepatitis B	0.00423	0.00492	CcSEcCtD
Tapentadol—Anxiety—Lamivudine—hepatitis B	0.00421	0.0049	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.0042	0.00489	CcSEcCtD
Tapentadol—Dry mouth—Lamivudine—hepatitis B	0.00413	0.00481	CcSEcCtD
Tapentadol—Confusional state—Lamivudine—hepatitis B	0.00408	0.00476	CcSEcCtD
Tapentadol—Oedema—Lamivudine—hepatitis B	0.00405	0.00472	CcSEcCtD
Tapentadol—Anaphylactic shock—Lamivudine—hepatitis B	0.00405	0.00472	CcSEcCtD
Tapentadol—Infection—Lamivudine—hepatitis B	0.00402	0.00469	CcSEcCtD
Tapentadol—Shock—Lamivudine—hepatitis B	0.00398	0.00464	CcSEcCtD
Tapentadol—Nervous system disorder—Lamivudine—hepatitis B	0.00397	0.00463	CcSEcCtD
Tapentadol—Skin disorder—Lamivudine—hepatitis B	0.00393	0.00458	CcSEcCtD
Tapentadol—Hyperhidrosis—Lamivudine—hepatitis B	0.00392	0.00456	CcSEcCtD
Tapentadol—Hypotension—Lamivudine—hepatitis B	0.00378	0.00441	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00369	0.0043	CcSEcCtD
Tapentadol—Insomnia—Lamivudine—hepatitis B	0.00366	0.00427	CcSEcCtD
Tapentadol—Paraesthesia—Lamivudine—hepatitis B	0.00364	0.00424	CcSEcCtD
Tapentadol—Dyspnoea—Lamivudine—hepatitis B	0.00361	0.00421	CcSEcCtD
Tapentadol—Somnolence—Lamivudine—hepatitis B	0.0036	0.00419	CcSEcCtD
Tapentadol—Dyspepsia—Lamivudine—hepatitis B	0.00357	0.00415	CcSEcCtD
Tapentadol—Decreased appetite—Lamivudine—hepatitis B	0.00352	0.0041	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Lamivudine—hepatitis B	0.0035	0.00407	CcSEcCtD
Tapentadol—Fatigue—Lamivudine—hepatitis B	0.00349	0.00407	CcSEcCtD
Tapentadol—Constipation—Lamivudine—hepatitis B	0.00346	0.00403	CcSEcCtD
Tapentadol—Feeling abnormal—Lamivudine—hepatitis B	0.00334	0.00389	CcSEcCtD
Tapentadol—Urticaria—Lamivudine—hepatitis B	0.00322	0.00375	CcSEcCtD
Tapentadol—Hypersensitivity—Lamivudine—hepatitis B	0.00298	0.00348	CcSEcCtD
Tapentadol—Asthenia—Lamivudine—hepatitis B	0.00291	0.00339	CcSEcCtD
Tapentadol—Pruritus—Lamivudine—hepatitis B	0.00287	0.00334	CcSEcCtD
Tapentadol—Diarrhoea—Lamivudine—hepatitis B	0.00277	0.00323	CcSEcCtD
Tapentadol—Dizziness—Lamivudine—hepatitis B	0.00268	0.00312	CcSEcCtD
Tapentadol—Vomiting—Lamivudine—hepatitis B	0.00258	0.003	CcSEcCtD
Tapentadol—Rash—Lamivudine—hepatitis B	0.00255	0.00297	CcSEcCtD
Tapentadol—Dermatitis—Lamivudine—hepatitis B	0.00255	0.00297	CcSEcCtD
Tapentadol—Headache—Lamivudine—hepatitis B	0.00254	0.00296	CcSEcCtD
Tapentadol—Nausea—Lamivudine—hepatitis B	0.00241	0.0028	CcSEcCtD
Tapentadol—UGT1A9—Phase II conjugation—GGT2—hepatitis B	0.00229	0.0162	CbGpPWpGaD
Tapentadol—CYP2C19—Xenobiotics—CYP2A6—hepatitis B	0.00213	0.015	CbGpPWpGaD
Tapentadol—CYP2C19—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00205	0.0145	CbGpPWpGaD
Tapentadol—CYP2D6—Xenobiotics—CYP2A6—hepatitis B	0.00196	0.0138	CbGpPWpGaD
Tapentadol—CYP2C9—Xenobiotics—CYP2A6—hepatitis B	0.00194	0.0137	CbGpPWpGaD
Tapentadol—CYP2D6—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00188	0.0133	CbGpPWpGaD
Tapentadol—UGT2B7—NRF2 pathway—GGT2—hepatitis B	0.00188	0.0133	CbGpPWpGaD
Tapentadol—CYP2C9—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00187	0.0132	CbGpPWpGaD
Tapentadol—SLC6A4—NRF2 pathway—GGT2—hepatitis B	0.00185	0.013	CbGpPWpGaD
Tapentadol—UGT2B7—Metapathway biotransformation—AKR1B1—hepatitis B	0.00169	0.012	CbGpPWpGaD
Tapentadol—UGT2B7—Biological oxidations—GGT2—hepatitis B	0.00165	0.0116	CbGpPWpGaD
Tapentadol—SLC6A2—NRF2 pathway—GGT2—hepatitis B	0.00159	0.0112	CbGpPWpGaD
Tapentadol—UGT1A9—NRF2 pathway—GGT2—hepatitis B	0.00152	0.0108	CbGpPWpGaD
Tapentadol—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.00146	0.0103	CbGpPWpGaD
Tapentadol—UGT1A9—Metapathway biotransformation—AKR1B1—hepatitis B	0.00138	0.00972	CbGpPWpGaD
Tapentadol—UGT1A9—Biological oxidations—GGT2—hepatitis B	0.00134	0.00945	CbGpPWpGaD
Tapentadol—CYP2C9—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.00133	0.00942	CbGpPWpGaD
Tapentadol—UGT2B7—Phase II conjugation—GGT1—hepatitis B	0.00133	0.0094	CbGpPWpGaD
Tapentadol—OPRD1—Peptide GPCRs—CCR5—hepatitis B	0.00122	0.00864	CbGpPWpGaD
Tapentadol—OPRM1—IL4-mediated signaling events—CD40LG—hepatitis B	0.00115	0.00816	CbGpPWpGaD
Tapentadol—OPRM1—IL4-mediated signaling events—IL10—hepatitis B	0.00115	0.00816	CbGpPWpGaD
Tapentadol—UGT2B7—NRF2 pathway—CYP2A6—hepatitis B	0.00114	0.00803	CbGpPWpGaD
Tapentadol—SLC6A4—NRF2 pathway—CYP2A6—hepatitis B	0.00112	0.00791	CbGpPWpGaD
Tapentadol—HTR3A—SIDS Susceptibility Pathways—IL10—hepatitis B	0.0011	0.00774	CbGpPWpGaD
Tapentadol—UGT1A9—Phase II conjugation—GGT1—hepatitis B	0.00108	0.00764	CbGpPWpGaD
Tapentadol—OPRK1—Peptide GPCRs—CCR5—hepatitis B	0.00107	0.00758	CbGpPWpGaD
Tapentadol—UGT2B7—Biological oxidations—CYP2A6—hepatitis B	0.000997	0.00704	CbGpPWpGaD
Tapentadol—SLC6A2—NRF2 pathway—CYP2A6—hepatitis B	0.000962	0.0068	CbGpPWpGaD
Tapentadol—SLC6A4—Monoamine Transport—TNF—hepatitis B	0.000924	0.00653	CbGpPWpGaD
Tapentadol—UGT1A9—NRF2 pathway—CYP2A6—hepatitis B	0.000924	0.00653	CbGpPWpGaD
Tapentadol—OPRM1—Peptide GPCRs—CCR5—hepatitis B	0.000907	0.00641	CbGpPWpGaD
Tapentadol—UGT2B7—NRF2 pathway—GGT1—hepatitis B	0.000887	0.00627	CbGpPWpGaD
Tapentadol—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000884	0.00625	CbGpPWpGaD
Tapentadol—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IFNG—hepatitis B	0.000882	0.00623	CbGpPWpGaD
Tapentadol—SLC6A4—NRF2 pathway—GGT1—hepatitis B	0.000874	0.00617	CbGpPWpGaD
Tapentadol—CYP2C19—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000873	0.00617	CbGpPWpGaD
Tapentadol—OPRM1—TCR Signaling Pathway—CD8A—hepatitis B	0.000848	0.00599	CbGpPWpGaD
Tapentadol—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000813	0.00575	CbGpPWpGaD
Tapentadol—UGT1A9—Biological oxidations—CYP2A6—hepatitis B	0.00081	0.00572	CbGpPWpGaD
Tapentadol—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000806	0.0057	CbGpPWpGaD
Tapentadol—CYP2D6—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000803	0.00567	CbGpPWpGaD
Tapentadol—CYP2C19—Arachidonic acid metabolism—GGT1—hepatitis B	0.000799	0.00564	CbGpPWpGaD
Tapentadol—CYP2C9—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000796	0.00562	CbGpPWpGaD
Tapentadol—SLC6A2—Monoamine Transport—TNF—hepatitis B	0.000795	0.00562	CbGpPWpGaD
Tapentadol—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—hepatitis B	0.000784	0.00554	CbGpPWpGaD
Tapentadol—UGT2B7—Biological oxidations—GGT1—hepatitis B	0.000778	0.0055	CbGpPWpGaD
Tapentadol—OPRM1—TCR Signaling Pathway—CCR5—hepatitis B	0.000775	0.00548	CbGpPWpGaD
Tapentadol—OPRM1—TCR Signaling Pathway—FAS—hepatitis B	0.000768	0.00543	CbGpPWpGaD
Tapentadol—SLC6A2—NRF2 pathway—GGT1—hepatitis B	0.000751	0.00531	CbGpPWpGaD
Tapentadol—OPRD1—Peptide ligand-binding receptors—CXCL10—hepatitis B	0.000742	0.00524	CbGpPWpGaD
Tapentadol—CYP2C9—Arachidonic acid metabolism—GGT1—hepatitis B	0.000728	0.00515	CbGpPWpGaD
Tapentadol—UGT1A9—NRF2 pathway—GGT1—hepatitis B	0.000721	0.00509	CbGpPWpGaD
Tapentadol—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000717	0.00506	CbGpPWpGaD
Tapentadol—SLC6A4—SIDS Susceptibility Pathways—IL10—hepatitis B	0.000684	0.00483	CbGpPWpGaD
Tapentadol—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000659	0.00466	CbGpPWpGaD
Tapentadol—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000654	0.00462	CbGpPWpGaD
Tapentadol—OPRK1—Peptide ligand-binding receptors—CXCL10—hepatitis B	0.000651	0.0046	CbGpPWpGaD
Tapentadol—CYP2C19—Metapathway biotransformation—AKR1B1—hepatitis B	0.000647	0.00457	CbGpPWpGaD
Tapentadol—UGT1A9—Biological oxidations—GGT1—hepatitis B	0.000633	0.00447	CbGpPWpGaD
Tapentadol—CYP2C19—Biological oxidations—GGT2—hepatitis B	0.000629	0.00444	CbGpPWpGaD
Tapentadol—OPRD1—G alpha (i) signalling events—CXCL10—hepatitis B	0.000626	0.00442	CbGpPWpGaD
Tapentadol—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TGFB1—hepatitis B	0.000611	0.00432	CbGpPWpGaD
Tapentadol—CYP2D6—Metapathway biotransformation—AKR1B1—hepatitis B	0.000595	0.0042	CbGpPWpGaD
Tapentadol—CYP2C9—Metapathway biotransformation—AKR1B1—hepatitis B	0.00059	0.00417	CbGpPWpGaD
Tapentadol—CYP2D6—Biological oxidations—GGT2—hepatitis B	0.000578	0.00408	CbGpPWpGaD
Tapentadol—OPRD1—Peptide ligand-binding receptors—CCR5—hepatitis B	0.000575	0.00406	CbGpPWpGaD
Tapentadol—CYP2C9—Biological oxidations—GGT2—hepatitis B	0.000573	0.00405	CbGpPWpGaD
Tapentadol—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—hepatitis B	0.000571	0.00403	CbGpPWpGaD
Tapentadol—HTR3A—SIDS Susceptibility Pathways—CTNNB1—hepatitis B	0.000553	0.00391	CbGpPWpGaD
Tapentadol—OPRM1—Peptide ligand-binding receptors—CXCL10—hepatitis B	0.00055	0.00388	CbGpPWpGaD
Tapentadol—OPRK1—G alpha (i) signalling events—CXCL10—hepatitis B	0.000549	0.00388	CbGpPWpGaD
Tapentadol—HTR3A—SIDS Susceptibility Pathways—NFKB1—hepatitis B	0.000536	0.00379	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000536	0.00378	CbGpPWpGaD
Tapentadol—OPRK1—Peptide ligand-binding receptors—CCR5—hepatitis B	0.000505	0.00356	CbGpPWpGaD
Tapentadol—SLC6A4—Circadian rythm related genes—FAS—hepatitis B	0.000501	0.00354	CbGpPWpGaD
Tapentadol—CYP2C19—Melatonin metabolism and effects—NFKB1—hepatitis B	0.000499	0.00352	CbGpPWpGaD
Tapentadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL10—hepatitis B	0.000498	0.00352	CbGpPWpGaD
Tapentadol—OPRD1—Peptide ligand-binding receptors—F2—hepatitis B	0.000494	0.00349	CbGpPWpGaD
Tapentadol—OPRM1—TCR Signaling Pathway—CD4—hepatitis B	0.000487	0.00344	CbGpPWpGaD
Tapentadol—OPRD1—G alpha (i) signalling events—CCR5—hepatitis B	0.000485	0.00343	CbGpPWpGaD
Tapentadol—OPRM1—G alpha (i) signalling events—CXCL10—hepatitis B	0.000464	0.00328	CbGpPWpGaD
Tapentadol—CYP2D6—Melatonin metabolism and effects—NFKB1—hepatitis B	0.000459	0.00324	CbGpPWpGaD
Tapentadol—OPRD1—GPCRs, Class A Rhodopsin-like—CCR5—hepatitis B	0.00045	0.00318	CbGpPWpGaD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL10—hepatitis B	0.000436	0.00308	CbGpPWpGaD
Tapentadol—OPRK1—Peptide ligand-binding receptors—F2—hepatitis B	0.000433	0.00306	CbGpPWpGaD
Tapentadol—SLC6A4—Circadian rythm related genes—NOS2—hepatitis B	0.000428	0.00302	CbGpPWpGaD
Tapentadol—OPRM1—Peptide ligand-binding receptors—CCR5—hepatitis B	0.000426	0.00301	CbGpPWpGaD
Tapentadol—OPRK1—G alpha (i) signalling events—CCR5—hepatitis B	0.000426	0.00301	CbGpPWpGaD
Tapentadol—OPRM1—TCR Signaling Pathway—NFKB1—hepatitis B	0.000419	0.00296	CbGpPWpGaD
Tapentadol—HTR3A—SIDS Susceptibility Pathways—TNF—hepatitis B	0.000417	0.00295	CbGpPWpGaD
Tapentadol—OPRK1—GPCRs, Class A Rhodopsin-like—CCR5—hepatitis B	0.000395	0.00279	CbGpPWpGaD
Tapentadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	0.000386	0.00273	CbGpPWpGaD
Tapentadol—CYP2C19—Biological oxidations—CYP2A6—hepatitis B	0.000381	0.00269	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—CXCL10—hepatitis B	0.000379	0.00268	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—hepatitis B	0.000369	0.00261	CbGpPWpGaD
Tapentadol—OPRM1—Peptide ligand-binding receptors—F2—hepatitis B	0.000366	0.00258	CbGpPWpGaD
Tapentadol—OPRM1—G alpha (i) signalling events—CCR5—hepatitis B	0.00036	0.00254	CbGpPWpGaD
Tapentadol—CYP2D6—Biological oxidations—CYP2A6—hepatitis B	0.00035	0.00247	CbGpPWpGaD
Tapentadol—OPRM1—TCR Signaling Pathway—TGFB1—hepatitis B	0.000349	0.00247	CbGpPWpGaD
Tapentadol—CYP2C9—Biological oxidations—CYP2A6—hepatitis B	0.000347	0.00245	CbGpPWpGaD
Tapentadol—SLC6A4—SIDS Susceptibility Pathways—CTNNB1—hepatitis B	0.000345	0.00244	CbGpPWpGaD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	0.000338	0.00239	CbGpPWpGaD
Tapentadol—HTR3A—SIDS Susceptibility Pathways—IL6—hepatitis B	0.000337	0.00238	CbGpPWpGaD
Tapentadol—SLC6A4—SIDS Susceptibility Pathways—NFKB1—hepatitis B	0.000335	0.00236	CbGpPWpGaD
Tapentadol—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—hepatitis B	0.000334	0.00236	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—CXCL10—hepatitis B	0.000332	0.00235	CbGpPWpGaD
Tapentadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	0.000331	0.00234	CbGpPWpGaD
Tapentadol—UGT2B7—NRF2 pathway—TGFB1—hepatitis B	0.000299	0.00211	CbGpPWpGaD
Tapentadol—CYP2C19—Biological oxidations—GGT1—hepatitis B	0.000297	0.0021	CbGpPWpGaD
Tapentadol—SLC6A4—NRF2 pathway—TGFB1—hepatitis B	0.000294	0.00208	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—CCR5—hepatitis B	0.000294	0.00208	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—AKR1B1—hepatitis B	0.000294	0.00207	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—RIT2—hepatitis B	0.000291	0.00206	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—SAG—hepatitis B	0.000291	0.00206	CbGpPWpGaD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	0.00029	0.00205	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	0.000286	0.00202	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—GGT2—hepatitis B	0.000281	0.00199	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—CXCL10—hepatitis B	0.000281	0.00198	CbGpPWpGaD
Tapentadol—SLC6A4—Circadian rythm related genes—PTEN—hepatitis B	0.000275	0.00194	CbGpPWpGaD
Tapentadol—CYP2D6—Biological oxidations—GGT1—hepatitis B	0.000273	0.00193	CbGpPWpGaD
Tapentadol—CYP2C9—Biological oxidations—GGT1—hepatitis B	0.000271	0.00192	CbGpPWpGaD
Tapentadol—OPRM1—TCR Signaling Pathway—IL6—hepatitis B	0.000263	0.00186	CbGpPWpGaD
Tapentadol—SLC6A4—SIDS Susceptibility Pathways—TNF—hepatitis B	0.00026	0.00184	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—CCR5—hepatitis B	0.000258	0.00182	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—RIT2—hepatitis B	0.000255	0.0018	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—SAG—hepatitis B	0.000255	0.0018	CbGpPWpGaD
Tapentadol—SLC6A2—NRF2 pathway—TGFB1—hepatitis B	0.000253	0.00179	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—F2—hepatitis B	0.000252	0.00178	CbGpPWpGaD
Tapentadol—SLC6A2—SLC-mediated transmembrane transport—ALB—hepatitis B	0.000252	0.00178	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000252	0.00178	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	0.000245	0.00173	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000243	0.00172	CbGpPWpGaD
Tapentadol—UGT1A9—NRF2 pathway—TGFB1—hepatitis B	0.000243	0.00171	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—AKR1B1—hepatitis B	0.000239	0.00169	CbGpPWpGaD
Tapentadol—HTR3A—Transmembrane transport of small molecules—ALB—hepatitis B	0.000238	0.00168	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.00023	0.00162	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—GGT2—hepatitis B	0.000229	0.00162	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—F2—hepatitis B	0.000221	0.00156	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—CCR5—hepatitis B	0.000218	0.00154	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—SAG—hepatitis B	0.000216	0.00152	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—RIT2—hepatitis B	0.000216	0.00152	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—CXCL10—hepatitis B	0.000214	0.00151	CbGpPWpGaD
Tapentadol—SLC6A4—SIDS Susceptibility Pathways—IL6—hepatitis B	0.00021	0.00148	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—CXCL10—hepatitis B	0.000194	0.00137	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—CXCL10—hepatitis B	0.000188	0.00133	CbGpPWpGaD
Tapentadol—SLC6A4—Circadian rythm related genes—TP53—hepatitis B	0.000187	0.00132	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—F2—hepatitis B	0.000187	0.00132	CbGpPWpGaD
Tapentadol—SLC6A4—Circadian rythm related genes—IL6—hepatitis B	0.000172	0.00121	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—CXCL10—hepatitis B	0.000171	0.0012	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—CYP2A6—hepatitis B	0.000171	0.0012	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—CCR5—hepatitis B	0.000166	0.00117	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—CXCL10—hepatitis B	0.000159	0.00112	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—GOT2—hepatitis B	0.000154	0.00109	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—CCR5—hepatitis B	0.000151	0.00107	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—CCR5—hepatitis B	0.000146	0.00103	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CXCL10—hepatitis B	0.000144	0.00102	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—F2—hepatitis B	0.000142	0.00101	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—CYP2A6—hepatitis B	0.000139	0.000979	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—GGT1—hepatitis B	0.000133	0.00094	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—GOT1—hepatitis B	0.000133	0.00094	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—CCR5—hepatitis B	0.000132	0.000934	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—F2—hepatitis B	0.000129	0.000914	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—ALB—hepatitis B	0.000129	0.000913	CbGpPWpGaD
Tapentadol—SLC6A2—Transmembrane transport of small molecules—ALB—hepatitis B	0.000128	0.000904	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—GOT2—hepatitis B	0.000125	0.000885	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—F2—hepatitis B	0.000125	0.000883	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—CCR5—hepatitis B	0.000123	0.00087	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CXCL10—hepatitis B	0.000115	0.000812	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000114	0.000806	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—F2—hepatitis B	0.000113	0.000802	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—AKR1B1—hepatitis B	0.000112	0.000792	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CCR5—hepatitis B	0.000112	0.00079	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—GOT1—hepatitis B	0.000108	0.000764	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—GGT1—hepatitis B	0.000108	0.000764	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GGT2—hepatitis B	0.000107	0.000759	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—F2—hepatitis B	0.000106	0.000746	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000104	0.000735	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—AKR1B1—hepatitis B	0.000103	0.000729	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—AKR1B1—hepatitis B	0.000102	0.000722	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CXCL10—hepatitis B	0.000101	0.000712	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GGT2—hepatitis B	9.89e-05	0.000698	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	9.86e-05	0.000696	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GGT2—hepatitis B	9.8e-05	0.000692	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—IL2—hepatitis B	9.6e-05	0.000678	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—F2—hepatitis B	9.59e-05	0.000677	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CCR5—hepatitis B	8.91e-05	0.000629	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—IL2—hepatitis B	8.71e-05	0.000616	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CXCL10—hepatitis B	8.51e-05	0.000601	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—IL2—hepatitis B	8.41e-05	0.000594	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CCR5—hepatitis B	7.81e-05	0.000552	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—F2—hepatitis B	7.64e-05	0.00054	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—IL2—hepatitis B	7.64e-05	0.00054	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—IL2—hepatitis B	7.11e-05	0.000502	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—ALB—hepatitis B	7.08e-05	0.0005	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—F2—hepatitis B	6.7e-05	0.000474	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CCR5—hepatitis B	6.6e-05	0.000466	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CYP2A6—hepatitis B	6.51e-05	0.00046	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—IL2—hepatitis B	6.46e-05	0.000456	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hepatitis B	6.07e-05	0.000429	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CYP2A6—hepatitis B	5.99e-05	0.000423	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CYP2A6—hepatitis B	5.94e-05	0.00042	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GOT2—hepatitis B	5.89e-05	0.000416	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—ALB—hepatitis B	5.75e-05	0.000406	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—F2—hepatitis B	5.66e-05	0.0004	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hepatitis B	5.54e-05	0.000391	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GOT2—hepatitis B	5.42e-05	0.000383	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PTEN—hepatitis B	5.4e-05	0.000382	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GOT2—hepatitis B	5.37e-05	0.000379	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—IL2—hepatitis B	5.15e-05	0.000364	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—IL6—hepatitis B	5.12e-05	0.000362	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GGT1—hepatitis B	5.08e-05	0.000359	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GOT1—hepatitis B	5.08e-05	0.000359	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CTNNB1—hepatitis B	4.97e-05	0.000351	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CDKN1A—hepatitis B	4.85e-05	0.000343	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—PTEN—hepatitis B	4.84e-05	0.000342	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—NFKB1—hepatitis B	4.82e-05	0.000341	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GGT1—hepatitis B	4.68e-05	0.00033	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GOT1—hepatitis B	4.68e-05	0.00033	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GOT1—hepatitis B	4.64e-05	0.000327	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GGT1—hepatitis B	4.64e-05	0.000327	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	4.63e-05	0.000327	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IL2—hepatitis B	4.51e-05	0.000319	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—IL6—hepatitis B	4.49e-05	0.000317	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PTEN—hepatitis B	4.39e-05	0.00031	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CTNNB1—hepatitis B	4.36e-05	0.000308	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CDKN1A—hepatitis B	4.26e-05	0.000301	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PTEN—hepatitis B	4.25e-05	0.0003	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NFKB1—hepatitis B	4.23e-05	0.000299	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	4.22e-05	0.000298	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—TGFB1—hepatitis B	4.02e-05	0.000284	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IL2—hepatitis B	3.81e-05	0.00027	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—IL6—hepatitis B	3.8e-05	0.000268	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CTNNB1—hepatitis B	3.68e-05	0.00026	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CDKN1A—hepatitis B	3.6e-05	0.000254	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PTEN—hepatitis B	3.59e-05	0.000254	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NFKB1—hepatitis B	3.57e-05	0.000252	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—TGFB1—hepatitis B	3.52e-05	0.000249	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—TP53—hepatitis B	3.31e-05	0.000234	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—IL6—hepatitis B	3.03e-05	0.000214	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—TGFB1—hepatitis B	2.98e-05	0.00021	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—TP53—hepatitis B	2.9e-05	0.000205	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—ALB—hepatitis B	2.7e-05	0.000191	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IL6—hepatitis B	2.65e-05	0.000187	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ALB—hepatitis B	2.49e-05	0.000176	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ALB—hepatitis B	2.47e-05	0.000174	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—TP53—hepatitis B	2.45e-05	0.000173	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IL6—hepatitis B	2.24e-05	0.000158	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PTEN—hepatitis B	2.06e-05	0.000146	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PTEN—hepatitis B	1.9e-05	0.000134	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PTEN—hepatitis B	1.88e-05	0.000133	CbGpPWpGaD
